NHS Launches Second MenB Vaccination Round Following Kent Outbreak
In response to a meningitis B outbreak in Kent, the NHS is providing a second dose of the vaccine to over 12,000 individuals who received the first round last month. The initiative aims to ensure full protection against the disease, which has claimed two lives and affected 19 others. The initial vaccination campaign targeted those potentially exposed, such as university students and schoolchildren in the region.
Eligibility and Vaccination Hubs
Clinics will open in Canterbury, Faversham, and Ashford, with online booking systems allowing eligible individuals to schedule appointments. NHS Kent and Medway has confirmed multiple locations will offer the second dose, with detailed booking instructions expected to be released from Monday. A second dose must be administered at least four weeks after the first, though delays are permitted.
The outbreak’s origin is linked to a local nightclub, prompting an expanded program that initially focused on university hall residents before reaching attendees of Club Chemistry. Additional groups, including sixth form students at schools with confirmed cases, were later included. Preventative antibiotics were also distributed to a broader population, leading to long lines at the University of Kent over several days.
Health Secretary Wes Streeting described the outbreak as “unprecedented,” highlighting the rapid spread among a large number of people in a short period. He noted the tragic loss of two individuals, including a 21-year-old university student and a sixth form pupil named Juliette Kenny, who both succumbed to the infection.
The NHS had previously introduced a routine MenB vaccination program for babies in 2015, but deferred teenage immunization due to cost considerations. At that time, UK health advisers concluded that a widespread catch-up campaign for adolescents was not economically viable. Teenagers are now routinely offered the MenACWY vaccine, which targets four meningitis strains but excludes MenB.
Following the Kent outbreak, Streeting has requested a review of the earlier decision by the Joint Committee on Vaccination and Immunisation (JCVI). The UK Health Security Agency (UKHSA) has declared a national incident to facilitate the distribution of resources, including antibiotics, during the response effort.
